ACME POCT
Tests COVID-19 Tests
The COVID-19 pandemic has presented unprecedented challenges including the critical need to efficiently develop accurate diagnostic tests to rapidly detect symptomatic and asymptomatic infections. The urgency to develop novel diagnostic devices and scale up existing testing technologies led Congress to appropriate $1.5 billion to the National Institutes of Health (NIH) which, in turn, established the Rapid Acceleration of Diagnostics (RADxSM) initiative with the overall goal to significantly expand the ability to mass screen Americans to preserve lives and facilitate the safe return to work and school.
ACME POCT was selected by RADxSM to conduct testing of COVID tests. The ACME POCT Test Verification Core was formed with these focal points for expertise and activities:
Laboratory and clinical device evaluation to understand the limit of viral detection, sensitivity, and specificity of candidate devices in controlled and community settings
Strengthened regulatory expertise to provide more focused attention to identify and overcome barriers to device approval and distribution
Usability testing from the perspective of patients and those using the tests to identify and overcome device limitations, and engineering assessment to evaluate robustness of design including human factors, manufacturability, and scalability.
In Metro-Atlanta? Sign Up to Get a COVID-19 Test With Us
Emory University, Georgia Institute of Technology, and Children's Healthcare of Atlanta are partnering with the National Institute of Health's (NIH) Rapid Acceleration of Diagnostics (RADx) program to evaluate and help bring more COVID-19 tests to market. We are looking for test samples and feedback from children and adults with COVID-19 symptoms.